Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis
- PMID: 17675316
- DOI: 10.1136/thx.2007.077784
Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis
Abstract
Background: A sensitive and valid non-invasive marker of early cystic fibrosis (CF) lung disease is sought. The lung clearance index (LCI) from multiple-breath washout (MBW) is known to detect abnormal lung function more readily than spirometry in children and teenagers with CF, but its relationship to structural lung abnormalities is unknown. A study was undertaken to determine the agreements between LCI and spirometry, respectively, with structural lung disease as measured by high-resolution computed tomography (HRCT) in children and teenagers with CF.
Methods: A retrospective study was performed in 44 consecutive patients with CF aged 5-19 years (mean 12 years). At an annual check-up inspiratory and expiratory HRCT scans, LCI and spirometric parameters (forced expiratory volume in 1 s (FEV1) and maximal expiratory flow when 75% of forced vital capacity was expired (FEF75)) were recorded. Abnormal structure was defined as a composite HRCT score of >5%, the presence of bronchiectasis or air trapping >30%. Abnormal lung function was defined as LCI above the predicted mean +1.96 residual standard deviations (RSD), or FEV1 or FEF75 below the predicted mean -1.96 RSD. Sensitivity/specificity assessments and correlation analyses were done.
Results: The sensitivity to detect abnormal lung structure was 85-94% for LCI, 19-26% for FEV1 and 62-75% for FEF75. Specificity was 43-65% for LCI, 89-100% for FEV1 and 75-88% for FEF75. LCI correlated better with HRCT scores (Rs +0.85) than FEV1 (-0.62) or FEF75 (-0.66).
Conclusions: LCI is a more sensitive indicator than FEV1 or FEF75 for detecting structural lung disease in CF, and a normal LCI almost excludes HRCT abnormalities. The finding of an abnormal LCI in some patients with normal HRCT scans suggests that LCI may be even more sensitive than HRCT scanning for detecting lung involvement in CF.
Comment in
-
Lung clearance index in CF: a sensitive marker of lung disease severity.Thorax. 2008 Feb;63(2):96-7. doi: 10.1136/thx.2007.082768. Thorax. 2008. PMID: 18234652 No abstract available.
Similar articles
-
Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.Thorax. 2004 Dec;59(12):1068-73. doi: 10.1136/thx.2004.022590. Thorax. 2004. PMID: 15563707 Free PMC article.
-
Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls.Ann Am Thorac Soc. 2020 Sep;17(9):1085-1093. doi: 10.1513/AnnalsATS.201905-375OC. Ann Am Thorac Soc. 2020. PMID: 32603187 Free PMC article.
-
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis.Am J Respir Crit Care Med. 2017 Feb 1;195(3):349-359. doi: 10.1164/rccm.201604-0893OC. Am J Respir Crit Care Med. 2017. PMID: 27575911 Clinical Trial.
-
Lung clearance index in the assessment of airways disease.Respir Med. 2009 Jun;103(6):793-9. doi: 10.1016/j.rmed.2009.01.025. Epub 2009 Feb 25. Respir Med. 2009. PMID: 19246184 Review.
-
Inert gas washout in preschool children.Paediatr Respir Rev. 2005 Dec;6(4):239-45. doi: 10.1016/j.prrv.2005.09.009. Epub 2005 Nov 9. Paediatr Respir Rev. 2005. PMID: 16298306 Review.
Cited by
-
Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series.J Pers Med. 2022 Aug 31;12(9):1421. doi: 10.3390/jpm12091421. J Pers Med. 2022. PMID: 36143206 Free PMC article.
-
Maximal mid-expiratory flow is a surrogate marker of lung clearance index for assessment of adults with bronchiectasis.Sci Rep. 2016 Jun 24;6:28467. doi: 10.1038/srep28467. Sci Rep. 2016. PMID: 27339787 Free PMC article.
-
Paediatric Thoracic Imaging in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulation.Children (Basel). 2024 Feb 16;11(2):256. doi: 10.3390/children11020256. Children (Basel). 2024. PMID: 38397368 Free PMC article. Review.
-
The short-term effects of ORKAMBI (lumacaftor/ivacaftor) on regional and distal lung structures using functional respiratory imaging.Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211046774. doi: 10.1177/17534666211046774. Ther Adv Respir Dis. 2021. PMID: 34541955 Free PMC article.
-
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium.Eur Respir Rev. 2022 Mar 23;31(163):210173. doi: 10.1183/16000617.0173-2021. Print 2022 Mar 31. Eur Respir Rev. 2022. PMID: 35321929 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical